UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know

UnitedHealth Group (UNH) closed the most recent trading day at $282.65, moving -1.88% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.01%. Meanwhile, the Dow experienced a drop of 0.32%, and the technology-dominated Nasdaq saw an increase of 0.05%. Shares of the largest U.S. health insurer witnessed a loss of 6.23% over the previous month, trailing the performance of the Medical sector with its loss of 1.59%, and the S&P 500's gain of 5.37%.Market participants will be closely following the financial results of UnitedHealth Group in its upcoming release. The company plans to announce its earnings on July 29, 2025. The company is predicted to post an EPS of $4.94, indicating a 27.35% decline compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $111.6 billion, up 12.89% from the year-ago period. UNH's full-year Zacks Consensus Estimates are calling for earnings of $21.38 per share and revenue of $448.65 billion. These results would represent year-over-year changes of -22.7% and +12.08%, respectively. Investors might also notice recent changes to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 4.02% decrease. UnitedHealth Group is currently a Zacks Rank #4 (Sell). Digging into valuation, UnitedHealth Group currently has a Forward P/E ratio of 13.47. This valuation marks a premium compared to its industry average Forward P/E of 12.97. We can also see that UNH currently has a PEG ratio of 1.41. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - HMOs industry had an average PEG ratio of 0.9 as trading concluded yesterday. The Medical - HMOs industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 239, finds itself in the bottom 4% echelons of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. 5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks